Filter
4686
Filtered Results: 4686
Text search:
drug
policy
Featured
Recommendations
380
New Publications
1303
Language
Document type
No document type
2968
Studies & Reports
681
Guidelines
523
Manuals
180
Strategic & Response Plan
152
Fact sheets
58
Training Material
49
Situation Updates
45
Infographics
11
Resource Platforms
8
Brochures
5
Online Courses
5
App
1
Countries / Regions
India
241
Kenya
158
Global
131
Uganda
117
South Africa
112
Western and Central Europe
111
Nigeria
107
Ethiopia
107
Nepal
95
Liberia
84
Malawi
81
Sierra Leone
80
Zambia
76
Myanmar / Burma
76
Tanzania
75
Ghana
70
Africa
65
Bangladesh
65
Latin America and the Carribbean
63
Eastern Europe
59
Ukraine
54
Rwanda
54
Namibia
50
Zimbabwe
45
Asia
41
Philippines
38
Lesotho
36
Cambodia
35
South–East Asia Region
35
Russia
33
Indonesia
32
Botswana
28
Eswatini/ Swaziland
23
Congo, Democratic Republic of
22
Mozambique
21
Syria
20
Senegal
20
Colombia
18
Burkina Faso
18
East and Southern Africa
15
Brazil
15
Venezuela
13
Germany
13
West and Central Africa
13
Cameroon
12
Haiti
12
Middle East and North Africa
12
Pakistan
12
Eastern Europe and Central Asia
11
South Sudan
11
Tajikistan
10
Thailand
10
Albania
10
Guinea
10
Georgia
10
Afghanistan
9
Peru
9
Sudan
9
Paraguay
8
USA
7
Vietnam
7
Moldova
7
North Macedonia
6
Benin
6
China
6
Laos
6
Armenia
6
Yemen
6
Mexico
5
Western Pacific Region
5
Sri Lanka
5
El Salvador
4
Jordan
4
United Kingdom
4
Argentina
4
Central African Republic
4
Libya
4
Bhutan
4
Iraq
4
Somalia
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Estonia
3
Kyrgyzstan
3
North America
3
Jamaica
3
Southern Africa
3
Bolivia
3
Lebanon
3
Palestine
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Romania
2
Poland
2
Mali
2
North Korea
1
Switzerland
1
Gambia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Egypt
1
Greece
1
Angola
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1901
Clinical Guidelines
375
Public Health
233
Women & Child Health
173
Key Resources
91
Capacity Building
52
Pharmacy & Technologies
52
Toolboxes
HIV
604
TB
518
Mental Health
453
AMR
246
COVID-19
177
Pharmacy
142
NTDs
92
NCDs
88
Caregiver
80
Rapid Response
67
Planetary Health
67
Ebola
62
Refugee
58
Global Health Education
56
Disability
53
Conflict
50
Health Financing Toolbox
31
Polio
23
Natural Hazards
17
Specific Hazards
14
Cholera
12
Social Ethics
10
Zika
7
Health Financing
1
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
Rev Panam Salud Publica 45, 2021 |
Pulmonary tuberculosis predictors and rapid molecular diagnosis
Preditores de tuberculose pulmonar e experiência com o diagnóstico molecular rápido
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Desde hace muchas décadas, los microbios, en particular las bacterias, se han vuelto cada vez más resistentes a diversos antimicrobianos. El aval de la Asamblea Mundial de la Salud al Plan de Acción Mundial sobre la resistencia a los antimicrobianos, en mayo de 2015, y la Declaración política d...
Despite its rich culture, great economic potential, high level of education and last but not least its sheer size – it is the largest state whose borders lie entirely within Europe and is 1.7 times the size of the Federal Republic of Germany – Ukraine seems far away in perception and awareness. ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
